Navigation Links
Neuralstem Grants Licenses For Central Nervous System Therapy Surgical Devices To Cedars-Sinai Medical Center
Date:2/20/2013

re the possibilities our technology has enabled."

About Neuralstem

Neuralstem's patented technology enables the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells constitutively into mature, physiologically relevant human neurons and glia. Neuralstem completed dosing of the last patient in an FDA-approved Phase I safety clinical trial for amyotrophic lateral sclerosis (ALS), often referred to as Lou Gehrig 's disease, in August 2012; the trial ends six months after that last surgery. Neuralstem has been awarded orphan status designation by the FDA for its ALS cell therapy.

In addition to ALS, the company is also targeting major central nervous system conditions with its NSI-566 cell therapy platform, including spinal cord injury, ischemic stroke and glioblastoma (brain cancer). The company received approval to commence a Phase I safety trial in chronic spinal cord injury in January 2013.

Neuralstem also has the ability to generate stable human neural stem cell lines suitable for the systematic screening of large chemical libraries. Through this proprietary screening technology, Neuralstem has discovered and patented compounds that may stimulate the brain's capacity to generate new neurons, possibly reversing the pathologies of some central nervous system conditions.  The company is in a Phase Ib safety trial evaluating NSI-189, its first neurogenic small molecule compound, for the treatment of major depressive disorder (MDD). Additional indications could include chronic traumatic encephalopathy (CTE), Alzheimer's disease, and post-traumatic stress disorder (PTSD).

For more information, please visit www.neuralstem.com or connect with us on Twitter,

SOURCE Neuralstem, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Neuralstem Updates ALS Stem Cell Trial Progress
2. Sixteenth Patient Dosed In Neuralstem ALS Stem Cell Trial
3. First Patients Dosed in Ib Phase of Neuralstems NSI-189 Trial in Major Depressive Disorder
4. Seventeenth Patient Dosed in Neuralstem ALS Stem Cell Trial
5. Neuralstem Announces Exercise Of Entire Over-Allotment Option By Aegis Capital Corp.
6. Neuralstem Grants First Licenses For CNS Therapy Surgical Devices
7. Neuralstem Announces Proposed Public Offering
8. Neuralstem to Raise $7.0 Million in Registered Direct Offering
9. Neuralstem President And CEO To Present At BIO CEO & Investor Conference 2013
10. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
11. Community Foundation Announces $2.6 Million In Grants From Centinela Medical Funds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... , May 27, 2015 OpportunityAnalyzer: Sepsis - ... Sepsis patients suffer from a series of diverse complications ... in the blood or tissues, which cause a rapidly ... to mortality rates near 50% depending on disease severity. ... healthcare systems of the global marketplace, which for the ...
(Date:5/27/2015)... 27, 2015 Protein purification involves the process ... in their physical properties. The objective of a protein ... functional protein with fewest contaminants. The global protein purification ... CAGR of around 5% to 6% during the forecast ... in the pharmaceutical and biotechnological fields, growing need to ...
(Date:5/27/2015)... DUBLIN , May 27, 2015 /PRNewswire/ ... Markets ( http://www.researchandmarkets.com/research/bnrjw5/2015_strategies ) has announced the addition ... Nucleic Acid Testing Market"  report to ... ,  , ,Major issues pertaining to the ... key economic, regulatory, demographic, social and technological ...
Breaking Medicine Technology:OpportunityAnalyzer: Sepsis - Opportunity Analysis and Forecasts to 2021 2OpportunityAnalyzer: Sepsis - Opportunity Analysis and Forecasts to 2021 3OpportunityAnalyzer: Sepsis - Opportunity Analysis and Forecasts to 2021 4Protein Purification & Isolation Market by Technology by Product by Application & End User - Global Forecast to 2020 2Protein Purification & Isolation Market by Technology by Product by Application & End User - Global Forecast to 2020 3United States Nucleic Acid Testing Market Strategies 2015-2020 2
... 28 Warner Chilcott plc (Nasdaq: WCRX ) ... Par Pharmaceutical, Inc. ("Par").  The Paragraph IV Certification Notice advises the Company ... for a generic version of the Company,s ASACOL 400 mg delayed release ... ASACOL 400 ...
... ANTONY, France , June 28, 2010 ... IIb/III clinical,trial (VO 57.07) conducted on Actair(R) sublingual allergen immunotherapy,tablets in allergic ... today announces the results of the second year of this,study. , ... Following this ...
Cached Medicine Technology:Warner Chilcott Announces Receipt of Paragraph IV Certification Notice 2Warner Chilcott Announces Receipt of Paragraph IV Certification Notice 3STALLERGENES: Persistent Efficacy Demonstrated After a Year on Actair(R) Followed by a Second Treatment-Free Year 2STALLERGENES: Persistent Efficacy Demonstrated After a Year on Actair(R) Followed by a Second Treatment-Free Year 3STALLERGENES: Persistent Efficacy Demonstrated After a Year on Actair(R) Followed by a Second Treatment-Free Year 4
(Date:5/28/2015)... (PRWEB) May 28, 2015 Dallas ... updated version of his patient education website ... redesign allows patients to readily access current educational ... dysfunction treatment, male urinary incontinence, prostate cancer treatment, ... of this website is to educate patients on ...
(Date:5/28/2015)... Portland, Ore. (PRWEB) May 28, 2015 ... announced today that it has been named a “Cool ... titled Cool Vendors in Healthcare Payers, 2015 ... J. Lheureux. The report highlights innovative vendors, products and ... into new trends in the health care payer market. ...
(Date:5/28/2015)... Sunshine Coast Health Center, one of ... at http://www.sunshinecoasthealthcentre.ca , is proud to announce ... the Toronto, Ontario, community. The company has a ... its online location information for Toronto residents. , ... we realize that addiction impacts family and friends," ...
(Date:5/28/2015)... 2015 The Cancer Solution: Taking Charge ... rewarding, researched and heartfelt book the Booksandauthor reviewer ... Westman for writing what should be one of the ... and there is power in action and this book has ... wants to talk about and unfortunately many persons know little ...
(Date:5/28/2015)... JJ Mowder-Tinney, PT, PhD, NCS, C/NDT, CSRS ... Physical Therapy Association (NYPTA) by the Delegation at their Delegate ... the NYPTA. At the National level, she was a ... Committee and an abstract reviewer for the Neurology Section Research ... member of the Program committee since 2010 and has held ...
Breaking Medicine News(10 mins):Health News:Mark Allen MD, Dallas Urologist, Launches Updated Patient Education Website With a Focus on Prostate Cancer and Erectile Dysfunction Treatment 2Health News:SpendWell Named a “Cool Vendor” by Gartner 2Health News:SpendWell Named a “Cool Vendor” by Gartner 3Health News:SpendWell Named a “Cool Vendor” by Gartner 4Health News:Toronto Alcohol Treatment and Drug Rehab Local Information Page Updated, Announces Sunshine Coast Health Center 2Health News:Toronto Alcohol Treatment and Drug Rehab Local Information Page Updated, Announces Sunshine Coast Health Center 3Health News:Booksandauthor Cites The Cancer Solution as One of the Most Important Books to Read 2
... hormonal changes, study found , WEDNESDAY, Sept. 5 (HealthDay ... post-traumatic stress disorder (PTSD) often experience the biological signs ... stress hormone cortisol, researchers report. , The research involved ... , A team of researchers from the Mount Sinai ...
... scientists say , , WEDNESDAY, Sept. 5 (HealthDay News) -- Two ... of them also increases the odds for lupus, according to ... the gene called STAT4 is one of the ... rheumatoid arthritis or lupus, both of which are autoimmune disorders, ...
... The National Association for Sport,and Physical Education ... to help to educate, challenge, and encourage all ... a healthy and fit life. As,the new sponsor ... Worldwide,will assist the nonprofit education association in promoting ...
... individual to a children,s hospital nationally, CHICAGO, Sept. ... Lurie has pledged $100 million to help fund,the new ... is the largest given by an individual to a ... gift, the largest charitable investment received in,the hospital,s 125-year ...
... 5 The Health Industry,Distributors Association (HIDA) announces ... structure by which administrative fees charged by group,purchasing ... products,distributors. "HIDA is calling for discussion on ... the fee structure for medical products distributors in,line ...
... Medical,Outsourcing announced today the appointment of Shawn Martin ... facility. With expertise as a,Distribution Supervisor for DePuy ... of experience as a former Captain in the ... development of Millstone,s new,Memphis service center, which will ...
Cached Medicine News:Health News:Parents' PTSD May Boost Stress in Offspring 2Health News:Genes Boost Risk for Rheumatoid Arthritis, Lupus 2Health News:Genes Boost Risk for Rheumatoid Arthritis, Lupus 3Health News:Genes Boost Risk for Rheumatoid Arthritis, Lupus 4Health News:National Association for Sport and Physical Education Partners with S&S Worldwide to Help Improve Children's Fitness 2Health News:National Association for Sport and Physical Education Partners with S&S Worldwide to Help Improve Children's Fitness 3Health News:Children's Memorial Hospital in Chicago Announces $100 Million Gift from Philanthropist Ann Lurie 2Health News:Children's Memorial Hospital in Chicago Announces $100 Million Gift from Philanthropist Ann Lurie 3Health News:HIDA Calls for Scrutiny of Group Purchasing Organization Distributor Fee Structure 2Health News:Millstone Medical Outsourcing Appoints Operations Manager of New Memphis, TN, Facility 2Health News:Millstone Medical Outsourcing Appoints Operations Manager of New Memphis, TN, Facility 3
... Atlas Eclipse model 995 is ... It offers ultra-low illumination and ... model 995 is ideal for ... lens specialists who require comprehensive ...
... is a corneal topographer that gives ... for refractive surgery, contact lens fitting ... fitting in a small 8.5" tall ... you need to supply is the ...
The only ergonomic work station of its kind with an optional built-in keratograph and flat-screen. The Concepta is a modern workstation for the examination and refraction of patients....
The natural look of 3 in 1 technology in virtually any prescription....
Medicine Products: